Allogene Therapeutics Inc (ALLO)
Operating Cash Flow (Statement)
-$32.00M
Quarterly · Period ending: · USD
ALLO Operating Cash Flow (Statement)
Latest reported-$32.00Mperiod ending
Latest reported-$32.00Mperiod ending
ALLO Quarterly Cash from Operations ($0.00 → -$32.00M)
Quarterly operating cash flow (statement)
High-resolution chart · PNG
ALLO operating cash flow (statement) history
Quarterly · USD. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | Operating Cash Flow (Statement) (USD) |
|---|---|
| -31,996,000 | |
| -12,913,000 | |
| -27,599,000 | |
| -29,688,000 | |
| -39,030,000 | |
| -52,929,000 | |
| -36,698,000 | |
| -44,115,000 | |
| -63,588,000 | |
| -55,899,000 | |
| -53,707,000 | |
| -55,530,000 | |
| -61,857,000 | |
| -66,639,000 | |
| -62,096,000 | |
| -47,655,000 | |
| -42,531,000 | |
| -68,237,000 | |
| -45,436,000 | |
| -48,878,000 | |
| -41,170,000 | |
| -49,328,000 | |
| -9,975,000 | |
| -37,588,000 | |
| -26,721,000 | |
| -40,809,000 | |
| -50,267,000 | |
| -31,935,000 | |
| -24,892,000 | |
| -30,256,000 | |
| -21,481,000 | |
| -17,130,000 | |
| -6,047,000 | |
| 5,000 | |
| 0 |